Geoffrey Cloud
Neurology — Alfred Health, Australia
Geoffrey Cloud
LeadR Profile
Neurology
Subspecialties: Cardiology - Hematology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 165
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Acute Ischaemic Stroke: Therapeutic Targets and Key Modulators of the Fibrinolytic System and Clot Formation. ischemic stroke, stroke, plasminogen, fibrinolysis, plasminogen activators, tissue plasminogen activator, fibrinolysin, therapeutics, tissues, fibrin | Transl Stroke Res | 2026 | 0 |
| Tenecteplase and other TNK formulations lose PAI-1 resistance in their 2-chain form: comparison with alteplase. plasminogen activator inhibitor 1, tissue plasminogen activator, fibrinogen, fibrinolysin, tenecteplase, hematologic diseases, fibrin | Blood Adv | 2026 | 1 |
| Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults. diabetes mellitus, dementia, cardiovascular diseases, drug-related side effects and adverse reactions, atorvastatin | N Engl J Med Top journal | 2026 | 7 |
| Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke: a multicentre randomised controlled trial. self-management, stroke, recycling, outcome assessment, health care, research, community support | Int J Stroke | 2026 | 0 |
| Heterogeneity of Treatment Effect of Aspirin and Clinically Significant Bleeding in Older Adults. hemorrhage, aspirin, therapeutics, forests | medRxiv | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke NCT06987643 — mitogens, ischemic stroke, stroke, recycling, capsules, enzymes | Phase 2 | Active not recruiting | 2025 |
| Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke NCT05105633 — sample size, ischemic stroke, stroke, plasminogen, central nervous system diseases, plasminogen activators, tissue plasminogen activator, brain, cardiovascular diseases, fibrin modulating agents, arteries, central nervous system, molecular mechanisms of pharmacological action, vascular diseases, brain diseases, cerebrovascular disorders, tenecteplase, nervous system, tissues, nervous system diseases, fibrin, basilar artery | Phase 2/Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map